Schacterle Amy bought ABOS
January 6, 2025 · Form 4 insider transaction
Schacterle Amy bought 13,200 shares of Acumen Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
13,200
Price
$0.00
Total value
N/A
InsiderSchacterle Amy
Role—
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 6, 2025
Filing dateJanuary 7, 2025
Shares owned after13,200
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to the option will vest in 48 equal monthly installments such that the option is fully vested on the fourth anniversary of the date of grant, subject to the Reporting Person's continuous service through each such vesting date.